Latest Warehousing News

Fisher & Paykel Healthcare posted a 14% revenue increase to NZ$2.31 billion and a 24% rise in net profit to NZ$468.5 million for FY2026, driven by strong hospital product sales and ongoing innovation.

Fortuna Metals has appointed mineral sands marketing veteran Ian Hind to lead its marketing strategy as it ramps up drilling at the Mkanda and Kampini rutile projects in Malawi, aiming to advance resource definition and commercial viability in 2026.

DGL Group reported a 5.8% revenue decline to $225.2 million in H1 FY26, weighed down by audit qualifications, ERP rollout delays, and one-off impairments. Despite these headwinds, the company cut net debt by $16.4 million and advanced strategic site consolidations and new facility investments.

DGL Group Limited (ASX: DGL) posted a statutory net loss of $12.8 million for the half year ended December 2025, impacted by non-cash write downs and operational costs, while progressing strategic initiatives including warehouse expansion and a new liquid waste treatment plant.

DGL Group Limited has replaced its ANZ-led financing with a new $120 million facility from ScotPac, extending maturity and enhancing working capital flexibility amid ongoing management restructuring.

MOVE Logistics Group reports a 98% improvement in normalised earnings before tax and a significant reduction in net debt, positioning the company on track for a profitable FY26 despite ongoing market challenges.

Cryosite Limited reported a robust half-year with revenue up 25% and net profit rising 36%, driven by strong demand in temperature-controlled logistics and a strategic warehouse acquisition that doubles its storage capacity.

Cromwell Property Group reported a 1.5% rise in operating profit and a 13.6% increase in assets under management, driven by strategic industrial acquisitions and robust portfolio performance.

ECS Botanics has partnered with Nimbus Health to distribute its medicinal cannabis products across Germany, marking its entry into Europe's largest cannabis market. The launch of the OzSun brand is set for April 2026, with premium Terphogz strains to follow later in the year.

Cyclopharm Limited is accelerating its US market push for Technegas with a A$16 million capital raise following a record 2025 sales performance. The company aims to expand its US installations and advance new clinical applications beyond pulmonary embolism.

Orthocell Ltd reports steady progress in commercialising its nerve repair product Remplir in the US, with sales growth, expanded distributor networks, and manufacturing upgrades underpinning its path to profitability.

EVE Health Group has completed manufacturing and distribution setup for Libbo™, its innovative oral dissolving film for erectile dysfunction, paving the way for near-term patient access via telehealth and pharmacy channels.